Accelerated postero-lateral spinal fusion by collagen scaffolds modified with engineered collagen-binding human bone morphogenetic protein-2 in rats

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Han, Xinglong ^a   Zhang, Wen ^a   Gu, Jun ^a   Zhao, Huan ^a   Ni, Li ^a   Han, Jiajun ^a   Zhou, Yun ^a   Gu, Yannan ^a   Zhu, Xuesong ^a   Sun, Jie ^b   Hou, Xianglin ^c   Yang, Huilin ^a   Dai, Jianwu ^c   Shi, Qin ^a  

^a SOOCHOW UNIVERSITY   (China)

^b SUZHOU INSTITUTE OF NANO TECH AND NANO BIONICS   (China)

^c INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; BMP2 PROTEIN, HUMAN; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; COLLAGEN BINDING DOMAIN; CONTROLLED STUDY; LUMBAR SPINE; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; PALPATION; POSTEROLATERAL SPINAL FUSION; PROTEIN BINDING; PROTEIN DOMAIN; RAT; SPINE FUSION; SPINE RADIOGRAPHY; STAINING; TRABECULAR BONE; ANALYSIS OF VARIANCE; ANIMAL; GENETIC ENGINEERING; GENETICS; HUMAN; LUMBAR VERTEBRA; METABOLISM; PROCEDURES; PROTEIN TERTIARY STRUCTURE; RADIOGRAPHY; SPRAGUE DAWLEY RAT; SURGERY; TISSUE SCAFFOLD;

ANALYSIS OF VARIANCE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; GENETIC ENGINEERING; HUMANS; LUMBAR VERTEBRAE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; SPINAL FUSION; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 84901625702     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098480     Document Type: Article

References (39)

1. Reid JJ, Johnson JS, Wang JC (2011) Challenges to bone formation in spinal fusion. J Biomech. 44: 213-220.
2. Kettler A, Rohlmann F, Ring C, Mack C, Wilke HJ (2011) Do early stages of lumbar intervertebral disc degeneration really cause instability? Evaluation of an in vitro database. Eur Spine J. 20: 578-584.
3. Alsaleh KA, Tougas CA, Roffey DM, Wai EK (2012) Osteoconductive bone graft extenders in posterolateral thoracolumbar spinal fusion. Spine(Phila Pa 1976) 37: 993-1000.
4. Geiger M, Li RH, Friess W (2003) Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 55: 1613-1629. (Pubitemid 37420006)
5. Dewan AK, Dewan RA, Calderon N, Fuentes A, Lazard Z, et al. (2010) Assessing mechanical integrity of spinal fusion by in situ endochondral osteoinduction in the murine model. J Orthop Surg Res 5: 58-67.
6. Lee SS, Huang BJ, Kaltz SR, Sur S, Newcomb CJ, et al. (2013) Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds. Biomaterials 34: 452-459.
7. Miyazaki M, Morishita Y, He W, Hu M, Sintuu C, et al. (2009) A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats. Spine J 9: 22-30.
8. Ben-David D, Srouji S, Shapira-Schweitzer K, Kossover O, Ivanir E, et al. (2013) Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen hydrogel matrix. Biomaterials 34: 2902-2910.
9. Carragee EJ, Chu G, Rohatgi R, Hurwitz EL, Weiner BK, et al. (2013) Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. J Bone Joint Surg Am 95: 1537-1545.
10. Shi Q, Li Y, Sun J, Zhang H, Chen L, et al. (2012) The osteogenesis of bacterial cellulose scaffold loaded with bone morphogenetic protein-2. Biomaterials 33: 6644-6649.
11. Chen B, Lin H, Zhao Y, Wang B, Zhao Y, et al. (2007) Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide. J Biomed Mater Res A 80: 428-434. (Pubitemid 46122677)
12. Chen B, Lin H, Wang J, Zhao Y, Wang B, et al. (2007) Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials 28: 1027-1035. (Pubitemid 44816374)
13. Zhao H, Guan HG, Gu J, Luo ZP, Zhang W, et al. (2013) Collagen membrane alleviates peritendinous adhesion in the rat Achilles tendon injury model. Chin Med J (Engl) 126: 729-733.
14. Lin H, Chen B, Wang B, Zhao Y, Sun W, et al. (2006) Novel nerve guidance material prepared from bovine aponeurosis. J Biomed Mater Res A 79: 591-598. (Pubitemid 44845173)
15. Hsieh CY, Hsieh HJ, Liu HC, Wang DM, Hou LT (2006) Fabrication and release behavior of a novel freeze-gelled chitosan/gamma-PGA scaffold as a carrier for rhBMP-2. Dent Mater 22: 622-629.
16. Kempen DH, Lu L, Hefferan TE, Creemers LB, Maran A, et al. (2008) Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 29:3245-3252.
17. Hannink G, Geutjes PJ, Daamen WF, Buma P (2013) Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2. J Mater Sci Mater Med 24: 325-332.
18. Lopez MJ, McIntosh KR, Spencer ND, Borneman JN, Horswell R, et al. (2009) Acceleration of Spinal Fusion Using Syngeneic and Allogeneic Adult Adipose Derived Stem Cells in a Rat Model. J Orthop Res 27: 366-373.
19. Crandall DG, Revella J, Patterson J, Huish E, Chang M, et al. (2013) Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis and degenerative disease - Part 2: BMP dosage related complications and long-term outcomes in 509 patients. Spine (Phila Pa 1976) 38: 1137-1145.
20. Dmitriev AE, Farhang S, Lehman RA Jr, Ling GS, Symes AJ (2010) Bone morphogenetic protein-2 used in spinal fusion with spinal cord injury penetrates intrathecally and elicits a functional signaling cascade. Spine J 10: 16-25.
21. Hsu HP, Zanella JM, Peckham SM, Spector M (2006) Comparing Ectopic Bone Growth Induced by rhBMP-2 on an Absorbable Collagen Sponge in Rat and Rabbit Models. J Orthop Res 24: 1660-1669. (Pubitemid 44203297)
22. Lee JW, Lee S, Lee SH, Yang HS, Im GI, et al. (2011) Improved spinal fusion efficacy by long-term delivery of bone morphogenetic protein-2 in a rabbit model. Acta Orthop 82: 756-760.
23. Park BH, Song KJ, Yoon SJ, Park HS, Jang KY, et al. (2011) Acceleration of spinal fusion using COMP-angiopoietin 1 with allografting in a rat model. Bone 49: 447-454.
24. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, et al. (2004) Combined Bone Morphogenetic Protein-2 and -7 Gene Transfer Enhances Osteoblastic Differentiation and Spine Fusion in a Rodent Model. J Bone Miner Res 19: 2021-2032. (Pubitemid 41103417)
25. Lu J, Bhargav D, Wei AQ, Diwan A (2008) Posterolateral Intertransverse Spinal Fusion Possible in Osteoporotic Rats With BMP-7 in a Higher Dose Delivered on a Composite Carrier. Spine (Phila Pa 1976) 33: 242-249.
26. Liao SS, Guan K, Cui FZ, Shi SS, Sun TS (2003) Lumbar Spinal Fusion With a Mineralized Collagen Matrix and rhBMP-2 in a Rabbit Model. Spine (Phila Pa 1976) 28: 1954-1960.
27. Rao RD, Bagaria V, Gourab K, Haworth ST, Shidham VB, et al. (2008) Autograft containment in posterolateral spine fusion. Spine J 8: 563-569. (Pubitemid 351894931)
28. Gupta MC, Khan SN (2005) Application of bone morphogenetic proteins in spinal fusion. Cytokine Growth Factor Rev 16: 347-355. (Pubitemid 40910323)
29. Carragee EJ, Hurwitz EL, Weiner BK (2011) A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11: 471-491.
30. Poynton AR, Lane JM (2002) Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine (Phila Pa 1976) 27: S40-S48.
31. Bae HW, Strenge KB, Ashraf N, Badura JM, Peckham SM, et al. (2012) Transient soft-tissue edema associated with implantation of increasing doses of rhBMP-2 on an absorbable collagen sponge in an ectopic rat model. J Bone Joint Surg Am 94: 1845-1852.
32. Devine JG, Dettori JR, France JC, Brodt E, McGuire RA (2012) The use of rhBMP in spine surgery: is there a cancer risk? Evid Based Spine Care J 3: 35-41.
33. Glassman SD, Carreon LY, Campbell MJ, Johnson JR, Puno RM, et al. (2008) The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion. Spine J 8: 443-448. (Pubitemid 351608965)
34. Koo KH, Lee JM, Ahn JM, Kim BS, La WG, et al. (2013) Controlled Delivery of Low-Dose Bone Morphogenetic Protein-2 Using Heparin-Conjugated Fibrin in the Posterolateral Lumbar Fusion of Rabbits. Artif Organs 37: 487-494.
35. Glassman SD, Carreon L, Djurasovic M, Campbell MJ, Puno RM, et al. (2007) Posterolateral lumbar spine fusion with INFUSE bone graft. Spine J 7: 44-49. (Pubitemid 46002546)
36. Park DK, Kim SS, Thakur N, Boden SD (2013) Use of Recombinant Human Bone Morphogenetic Protein-2 with Local Bone Graft Instead of Iliac Crest Bone Graft in Posterolateral Lumbar Spine Arthrodesis. Spine (Phila Pa 1976) 38:E738-E747
37. Boerckel JD, Kolambkar YM, Dupont KM, Uhrig BA, Phelps EA, et al. (2011) Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 32: 5241-5251.
38. Drespe IH, Polzhofer GK, Turner AS, Grauer JN (2005) Animal models for spinal fusion. Spine J 5: 209S-216S. (Pubitemid 41700063)
39. Schimandle JH, Boden SD (1994) Spine update. The use of animal models to study spinal fusion. Spine (Phila Pa 1976) 19: 1998-2006.